Are you planning the acquisition, merger, or licensing of a company?

Do you simply wish to sell your company?

You have therefore considered, examined, and refined the balance sheets and income statements to highlight the essential information in terms of profitability and business projections.

However, in evaluating the transaction, have you considered a regulatory financial audit?

Identifying regulatory compliance and potential is essential in characterizing the risk at this crucial stage in the life of the target company.

CLEAR has comprehensive experience in assessing the regulatory compliance of the project, estimating potential future scientific investments, and evaluating the economic impacts resulting from a potentially degraded regulatory situation.

With CLEAR, you have an efficient tool to, depending on the case:

  1. Secure the transaction
  2. Contribute to the valuation of the company.

Measuring acquisition risk means:

  1. Validating the regulatory compliance of a product range or an industrial site
  2. Identifying regulatory gaps
  3. Calculating the cost of upgrading

Investors, investment banks, and professionals in the cosmetics sector rely on CLEAR's experience and network to strengthen strategic audits, evaluate the development potential of a company within its sector, or analyze the adequacy of regulatory means and resources in relation to the challenges presented in the business plan.

The audit takes place in two phases:

1. REGULATORY PREVIEW (Formula review, regulatory and toxicological compliance according to current EU/UK requirements, establishment of ingredient list, determination of necessary tests (safety and efficacy if marketing brief is available).

2. AUDIT and FINAL REPORT according to an evolving specification:

  • The audit of compliance with current regulations in Europe and the UK. Evaluation of regulatory impact over 3 and 5 years. Identification of gaps in (1) composition, (2) claims/indications, (3) market release procedure (date of market entry).
  • The audit of regulatory and scientific investments to ensure the maintenance of products on the market (according to new regulatory requirements, new countries of commercialization).
  • The support of external partners to audit industrial sites according to ISO 22716 (Good Manufacturing Practices).
  • The evaluation of gaps, assessment of regulatory and human resources needed to bring the brand or company into compliance.